EXICURE, INC. Public Float
EXICURE, INC. (XCUR) had Public Float of $16.40 million as of 2025-06-30, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-25
- 2025-06-30: Entity Public Float $16.40M.
- 2024-06-28: Entity Public Float $7.60M.
- 2023-06-30: Entity Public Float $5.80M.
- 2022-06-30: Entity Public Float $8.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $16.40M 10-K · filed 2026-03-25 |
| 2024-06-28 | $7.60M 10-K · filed 2025-03-18 |
| 2023-06-30 | $5.80M 10-K · filed 2024-06-06 |
| 2022-06-30 | $8.90M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $114.90M 10-K · filed 2022-03-25 |
| 2020-06-30 | $128.10M 10-K · filed 2021-03-11 |
| 2019-06-28 | $71.50M 10-K · filed 2020-03-10 |
| 2018-06-30 | $117.60M 10-K/A · filed 2019-09-23 |
| 2017-06-30 | $0.00 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |